bpV(phen) trihydrate,一种胰岛素模拟物,是一种有效的蛋白酪氨酸磷酸酶 (PTP) 和PTEN抑制剂,对PTEN,PTP-β和PTP-1B的IC50为 38 nM,343 nM 和 920 nM。bpV(phen) trihydrate 在体外抑制原生动物寄生虫利什曼原虫的增殖。bpV(phen) trihydrate 强烈诱导大量趋化因子和促炎性细胞因子的分泌,并激活Th1型途径 (IL-12,IFNγ)。bpV(phen) trihydrate 还可以诱导细胞凋亡 (apoptosis),并具有抗血管生成和抗肿瘤活性。
生物活性 | bpV(phen) trihydrate, a insulin-mimetic agent, is a potentprotein tyrosinephosphatase(PTP)andPTENinhibitor withIC50s of 38 nM, 343 nM and 920 nM forPTEN,PTP-βandPTP-1B, respectively. bpV(phen) trihydrate inhibits proliferation of the protozoanparasiteLeishmaniain vitro. bpV(phen) trihydrate strongly induces the secretion of a large number of chemokines and pro-inflammatory cytokines, and it activates aTh1-typepathway (IL-12, IFNγ). bpV(phen) trihydrate can also induce cellapoptosis, and has anti-angiogenic and anti-tumor activity[1][2][3][4][5]. |
IC50& Target | IC50: 38 nM (PTEN), 343 nM (PTP-β) and 920 nM (PTP-1B)[3] ParasiteLeishmania[2] Apoptosis[1] |
体外研究 (In Vitro) | bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment causes a further decrease of cell viability in H/R-injured H9c2 cells[1]. bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment increases the apoptosis of H/R-injured H9c2 cells[1]. bpV(phen) (5 μM; 24.5 hours; H9c2 cells) treatment significantly promotes the accumulation of cytoplasmic Cytochrome C in H/R-injured H9c2 cells[1]. After stimulation of bpV(phen), PTEN-induced putative kinase protein 1 (PINK1)/Parkin-mediated mitophagy is inhibited[1]. bpV(phen) is an insulin-mimetic agent following insulin-receptor tyrosine kinase hyperphosphorylation and activation[4].
Cell Viability Assay[1] Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells | Concentration: | 5 μM | Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) | Result: | Caused a further decrease of cell viability. |
Apoptosis Analysis[1] Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells | Concentration: | 5 μM | Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) | Result: | Increased the apoptosis of H/R-injured H9c2 cells. |
Western Blot Analysis[1] Cell Line: | Hypoxia/reoxygenation (H/R)-injured H9c2 cells | Concentration: | 5 μM | Incubation Time: | 24.5 hours (hypoxia for 24 h; reoxygenation for 30 minutes) | Result: | Showed an increased release of Cytochrome C. |
|
体内研究 (In Vivo) | bpV(phen) (5 mg/kg; intraperitoneal injection; daily; for 38 days; male BALB/c nude (nu/nu) athymic mice) treatment causes a significant reduction in average tumor volume[1].
Animal Model: | Male BALB/c nude (nu/nu) athymic mice (6-7 weeks old) injected with PC-3 cells[2] | Dosage: | 5 mg/kg | Administration: | Intraperitoneal injection; daily; for 38 days | Result: | Caused a significant reduction in average tumor volume. |
|
分子量 | |
性状 | |
Formula | |
CAS 号 | |
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
溶解性数据 | In Vitro: H2O : 18.18 mg/mL(44.97 mM;Need ultrasonic) 配制储备液 1 mM | 2.4735 mL | 12.3674 mL | 24.7347 mL | 5 mM | 0.4947 mL | 2.4735 mL | 4.9469 mL | 10 mM | 0.2473 mL | 1.2367 mL | 2.4735 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: PBS Solubility: 25 mg/mL (61.84 mM); Clear solution; Need ultrasonic and warming
*以上所有助溶剂都可在本网站选购。 |